Does Starbucks Coffee Cause Cancer?

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Does Starbucks Coffee Cause Cancer?

© Thinkstock

Some scientists believe that a chemical in coffee causes cancer. A lawsuit in California could conclude in a judgment that would support that. Since Starbucks Corp. (NYSE: SBUX) is the primary target of the action, it may have to find a new way to sell or label products.

The Metzger Law Group filed a suit — Council for Education and Research on Toxics v. Starbucks Corporation, et al. — that uses this as its basis:

Acrylamide is an industrial carcinogen which, in recent years, has unfortunately been recognized as a substantial constituent of many foods we eat. In 2002, Swedish researchers published an important study showing that potatoes and certain other foods heated at high temperatures contain very high levels of acrylamide. The highest levels of the carcinogen were found in french fries and potato chips, but high levels of acrylamide have also been found in cereals, breads, and coffee. Subsequent research established that acrylamide was formed by a chemical process known as the Maillard reaction in which asparagine, a common constituent of many foods, when being heated at high temperatures, produces acrylamide.

CNBC reports that the lawsuit “resumed Monday.”

[nativounit]

The suit is another example of what companies face because of the hundreds of potentially dangerous ingredients and chemicals in products sold to Americans every day. Some dangers are obvious, as is the case with cigarettes. The acrylamide effect on humans may be harder to prove. However, that does not mean a court will not rule against Starbucks. Such a ruling probably would set off appeals that could go on for years. In the meantime, Starbucks might have to warn customers of the dangers. Certainly, the bad publicity would represent a hurdle for the world’s largest coffee chain.

CNBC issued a long story on the lawsuit. That, in and of itself, creates a problem for Starbucks. It faces the perception that it is doing something bad for its customers.

[wallst_email_signup]

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618